Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Yujun Li's publication output changed over time?
ScholarIQpublication output · 2008–2023
Output grew100% over the shown period — from 1 works in 2008 to 2 in 2023.
1
1
2
1
1
1
2
2
20082009201520172018201920202023
What are the most-cited papers on Yujun Li?
ScholarIQmost cited works
Self‐Assembly of Therapeutic Peptide into Stimuli‐Responsive Clustered Nanohybrids for Cancer‐Targeted Therapy
Wangxiao He, Simeng Wang, Jin Yan, Yiping Qu, Liang Jin, Fang Sui, Yujun Li, Weiming You, Guang Yang, Qi Yang, Meiju Ji, Yongping Shao, X. Peter, Wuyuan Lu, Peng Hou
S135204980. 201982 CitationsOPEN ACCESS
Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients
Zhao‐Xu Chen, Huiqing Jia, Huina Zhang, Lifang Chen, Peng Zhao, Jing Zhao, Guangming Fu, Xiaoming Xing, Yujun Li, Chengqin Wang
Breast Cancer Research and Treatment. 202351 CitationsOPEN ACCESS
Primary cardiac leiomyosarcoma: An analysis of clinical characteristics and outcome patterns
Jigang Wang, Li Cui, Tao Jiang, Yujun Li, Zhimin Wei
S207218074. 201549 Citations
The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis‐Mediated Innate Immune Response
Weiwei Fu, Hong Li, Haiyang Fu, Shuchao Zhao, Weiping Shi, Mengqi Sun, Yujun Li
S4210178340. 202048 CitationsOPEN ACCESS
Genetic analysis and clinicopathological features of <i><scp>ALK</scp></i>‐rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review
Wenjuan Yu, Yuewei Wang, Yanxia Jiang, Wei Zhang, Yujun Li
S14376486. 201747 Citations
Related on ScholarIQ
Qingdao University
Institution
Self‐Assembly of Therapeutic Peptide into Stimuli‐Responsive Clustered Nanohybrids for Cancer‐Targeted Therapy
Paper
Is HER2 ultra-low breast cancer different from HER2 null or HER2 low breast cancer? A study of 1363 patients
Paper
Primary cardiac leiomyosarcoma: An analysis of clinical characteristics and outcome patterns
Paper
The SIRT3 and SIRT6 Promote Prostate Cancer Progression by Inhibiting Necroptosis‐Mediated Innate Immune Response
Paper
Genetic analysis and clinicopathological features of <i><scp>ALK</scp></i>‐rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review
Paper